|
|
|
Volumn 47, Issue 9 SUPPL., 2002, Pages 777-779
|
|
Injectable contraception: Introduction to the symposium
|
|
Author keywords
Contraceptive agents, female; Depomedroxyprogesterone acetate; DMPA; Injectable contraceptives; MPA E2c
|
|
Indexed keywords
ESTRADIOL CYPIONATE PLUS MEDROXYPROGESTERONE ACETATE;
GESTAGEN;
INJECTABLE CONTRACEPTIVE AGENT;
MEDROXYPROGESTERONE ACETATE;
ORAL CONTRACEPTIVE AGENT;
CONTRACEPTIVE AGENT;
DRUG DERIVATIVE;
ESTRADIOL;
ESTRADIOL 17 BETA CYPIONATE;
ESTRADIOL 17 BETA-CYPIONATE;
AMENORRHEA;
BIRTH CONTROL;
BODY WEIGHT DISORDER;
BONE ATROPHY;
BONE DENSITY;
CONFERENCE PAPER;
CONTRACEPTION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
FRACTURE;
HUMAN;
MENSTRUATION DISORDER;
OSTEOPOROSIS;
PATIENT COMPLIANCE;
PATIENT SATISFACTION;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
ADULT;
ARTICLE;
ATTITUDE TO HEALTH;
DELAYED RELEASE FORMULATION;
INTRAMUSCULAR DRUG ADMINISTRATION;
PATIENT EDUCATION;
UNITED STATES;
WOMEN'S HEALTH;
ADULT;
CONTRACEPTIVE AGENTS, FEMALE;
DELAYED-ACTION PREPARATIONS;
ESTRADIOL;
FEMALE;
HEALTH KNOWLEDGE, ATTITUDES, PRACTICE;
HUMANS;
INJECTIONS, INTRAMUSCULAR;
MEDROXYPROGESTERONE 17-ACETATE;
PATIENT COMPLIANCE;
PATIENT EDUCATION;
UNITED STATES;
WOMEN'S HEALTH;
|
|
EID: 0036744677
PISSN: 00247758
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (7)
|
